U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
100261100261Cardiac Monitoring of Post-Operative Cancer Patients Experiencing Atrial FibrillationTerminatedNo Results AvailablePost-Operative Cancer Patients Experiencing Atrial|FibrillationBehavioral: questionnaire about the use of ECG devicehttps://ClinicalTrials.gov/show/NCT01253590
100262100262A Clinical Evaluation of a Steroid-Coated Sinus Stent When Used Following Functional Endoscopic Sinus Surgery in Patients With Chronic SinusitisCompletedHas ResultsChronic SinusitisDevice: Sinus Stent with drug coating|Device: Non Coated Sinus Stenthttps://ClinicalTrials.gov/show/NCT01253577
100263100263A Study of RO5185426 in Previously Treated Melanoma Patients With Brain MetastasesCompletedHas ResultsMalignant MelanomaDrug: RO5185426https://ClinicalTrials.gov/show/NCT01253564
100264100264VX-950HEP1001 - Drug-drug Interaction Study Between Telaprevir and RaltegravirCompletedNo Results AvailableHepatitis CDrug: Treatment sequence AB|Drug: Treatment sequence BAhttps://ClinicalTrials.gov/show/NCT01253551
100265100265Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Populations Using Formula Feeding (PROMISE)Active, not recruitingNo Results AvailableHIVDrug: Zidovudine (ZDV)|Drug: Nevirapine (NVP)|Drug: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV])|Drug: Lamivudine-Zidovudine (3TC-ZDV)|Drug: Lopinavir-ritonavir (LPV-RTV)https://ClinicalTrials.gov/show/NCT01253538
100266100266Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric AdenocarcinomasCompletedHas ResultsAdenocarcinomaBiological: Ramucirumab (IMC-1121B )|Drug: Paclitaxelhttps://ClinicalTrials.gov/show/NCT01253525
100267100267Study to Assess the Safety and Efficacy of THR-18 When Administered to Patients Suffering Acute Ischemic Stroke and Treated With Tissue Plasminogen Activator (tPA)Not yet recruitingNo Results AvailableAcute Ischemic StrokeDrug: THR-18|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01253512
100268100268Multiple Dose Study of TRx0037CompletedNo Results AvailableAlzheimer's DiseaseDrug: TRx0037https://ClinicalTrials.gov/show/NCT01253499
100269100269Expressive Writing for Heart HealingCompletedNo Results AvailableIschemic Heart Disease|ObesityBehavioral: Disease-related Expressive writing|Behavioral: Active Comparator: Traditional expressive writing|Behavioral: Sham Comparator: Neutral writinghttps://ClinicalTrials.gov/show/NCT01253486
100270100270Symbicort in Airway Predominant Chronic Obstructive Pulmonary Disease (COPD)RecruitingNo Results AvailablePulmonary Disease, Chronic ObstructiveDrug: Budesonide|Drug: budesonide/formoterol|Drug: Ipratropium/albuterolhttps://ClinicalTrials.gov/show/NCT01253473
100271100271Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)RecruitingNo Results AvailableLeukemiaDrug: Cyclophosphamide|Drug: Rituximab|Drug: Sapacitabinehttps://ClinicalTrials.gov/show/NCT01253460
100272100272AKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedHas ResultsAdult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute MyeloblastDrug: Akt inhibitor MK2206|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01253447
100273100273E2022 Patch Formulation Single Dose Phase I StudyCompletedNo Results AvailableJapanese Healthy Male Adult VolunteersDrug: E2022|Drug: E2022|Drug: E2022|Drug: E2022|Drug: E2022https://ClinicalTrials.gov/show/NCT01253434
100274100274The Effects of Dopamine on Reward ProcessingRecruitingNo Results AvailableMajor Depressive Disorder (MDD)Drug: Amisulpride|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01253421
100275100275Effect of Cannabinoid Agonist on Gastrointestinal and Colonic Motor Functions in Patients With Irritable Bowel Syndrome (IBS)CompletedHas ResultsIrritable Bowel SyndromeDrug: Dronabinol|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01253408
100276100276Exercise for FibromyalgiaCompletedNo Results AvailableFibromyalgiaBehavioral: Strength training|Behavioral: Aerobic exercisehttps://ClinicalTrials.gov/show/NCT01253395
100277100277Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary AngioedemaWithdrawnNo Results AvailableHereditary AngioedemaBiological: ecallantidehttps://ClinicalTrials.gov/show/NCT01253382
100278100278Pazopanib in Patients With Relapsed or Refractory Small Cell Lung CancerActive, not recruitingNo Results AvailableSmall Cell Lung Cancer|Lung Cancer|SCLCDrug: Pazopanibhttps://ClinicalTrials.gov/show/NCT01253369
100279100279ACTIONS - Aortic Counterpulsation to Improve Outcomes in Noncardiac SurgeryTerminatedNo Results AvailablePatients With History of Ischemic Heart Disease With LV Dysfunction Undergoing Noncardiac SurgeryDevice: IABPhttps://ClinicalTrials.gov/show/NCT01253356
100280100280Pediatric Aggression and ViolenceCompletedHas ResultsPediatric Aggression and Violencehttps://ClinicalTrials.gov/show/NCT01253343
100281100281Usage, Usability & Effect on Adherence and Clinical Outcomes of Text Message Reminders for Adolescents With AsthmaRecruitingNo Results AvailableAsthmaOther: Text Message Remindershttps://ClinicalTrials.gov/show/NCT01253330
100282100282Treatment of Rett Syndrome With rhIGF-1 (Mecasermin [rDNA]Injection)CompletedNo Results AvailableRett SyndromeDrug: rhIGF-1https://ClinicalTrials.gov/show/NCT01253317
100283100283A Single Dose Study of LY2189265 in Subjects With Varying Degrees of Hepatic (Liver) ImpairmentCompletedHas ResultsDiabetes Mellitus, Type 2Drug: LY2189265https://ClinicalTrials.gov/show/NCT01253304
100284100284A Study of Japanese Rheumatoid Arthritis PatientsCompletedNo Results AvailableRheumatoid ArthritisDrug: LY2127399https://ClinicalTrials.gov/show/NCT01253291
100285100285A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus PatientsCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: LY2393910|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01253278
100286100286A Study in Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid ArthritisDrug: LY2439821|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01253265
100287100287Endoprosthesis Treatment Effects on Human Abdominal Aorta Aneurysms (AAA) Metabolic ActivityCompletedNo Results AvailableAbdominal Aortic AneurysmRadiation: [18F] Fluorodeoxyglucose PET Scan Imaging|Radiation: CT scan|Biological: Blood sampling for biological investigationshttps://ClinicalTrials.gov/show/NCT01253252
100288100288Evaluation the TECNIS IOL in Both Eyes VS the ReZoom IOL in One and TECNIS IOL in the OppositeRecruitingNo Results AvailableCataract Extractionhttps://ClinicalTrials.gov/show/NCT01253239
100289100289A Study for Japanese Patients With Rheumatoid ArthritisCompletedNo Results AvailableRheumatoid ArthritisDrug: LY2127399|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01253226
100290100290BR55 in Prostate Cancer: an Exploratory Clinical TrialCompletedNo Results AvailableProstate CancerDrug: BR55https://ClinicalTrials.gov/show/NCT01253213

* Görseller ve İçerik tekif hakkına sahip olabilir